Home  »  Hot Stocks   »  Wall Street Pummels Cloopen Group Holding Limited ...

Wall Street Pummels Cloopen Group Holding Limited (RAAS) After Recent Earnings Report

Cloopen Group Holding Limited (NYSE:RAAS) went down by -8.08% from its latest closing price compared to the recent 1-year high of $4.46. The company’s stock price has collected -17.97% of loss in the last five trading sessions.

Is It Worth Investing in Cloopen Group Holding Limited (NYSE :RAAS) Right Now?

Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Cloopen Group Holding Limited declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


RAAS currently public float of 69.36M and currently shorts hold a 0.85% ratio of that float. Today, the average trading volume of RAAS was 83.38K shares.

RAAS’s Market Performance

RAAS stocks went down by -17.97% for the week, with a monthly drop of -15.70% and a quarterly performance of -31.88%, while its annual performance rate touched -81.44%. The volatility ratio for the week stands at 9.32% while the volatility levels for the past 30 days are set at 9.01% for Cloopen Group Holding Limited. The simple moving average for the period of the last 20 days is -19.52% for RAAS stocks with a simple moving average of -36.50% for the last 200 days.

Analysts’ Opinion of RAAS

Many brokerage firms have already submitted their reports for RAAS stocks, with Goldman repeating the rating for RAAS by listing it as a “Neutral.” The predicted price for RAAS in the upcoming period, according to Goldman is $16.20 based on the research report published on March 08th of the previous year 2021.

Citigroup, on the other hand, stated in their research note that they expect to see RAAS reach a price target of $27. The rating they have provided for RAAS stocks is “Buy” according to the report published on March 08th, 2021.

RAAS Trading at -17.99% from the 50-Day Moving Average

After a stumble in the market that brought RAAS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.89% of loss for the given period.

Volatility was left at 9.01%, however, over the last 30 days, the volatility rate increased by 9.32%, as shares sank -18.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.71% lower at present.

During the last 5 trading sessions, RAAS fell by -17.97%, which changed the moving average for the period of 200-days by -60.88% in comparison to the 20-day moving average, which settled at $0.9391. In addition, Cloopen Group Holding Limited saw -73.69% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for RAAS

Equity return is now at value -650.90, with -224.90 for asset returns.

Is CVS Health Corporation (CVS) a Keeper?

CVS Health Corporation (NYSE:CVS) went up by 0.55% from its latest closing price compared to the recent 1-year high of $111.25. The company’s stock price